W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Catalog Number TGMR404020J |
Device Problem
No Apparent Adverse Event (3189)
|
Patient Problem
Aneurysm (1708)
|
Event Date 09/03/2022 |
Event Type
Injury
|
Event Description
|
On (b)(6) 2016, this patient underwent endovascular treatment using gore® excluder® aaa endoprosthesis for bilateral internal iliac aneurysm.The right and left internal iliac arteries were embolized, and excluder limbs were placed from the right and left common iliac artery to the external iliac artery.Minor proximal type i endoleaks were identified bilaterally, but no specific treatment was performed.The patient tolerated the procedure.(captured in new case #(b)(4)).On (b)(6) 2022, this patient underwent endovascular treatment of a descending aorta aneurysm using gore® tag® conformable thoracic stent graft with active control system (ctag/ac).When the first ctag/ac was deployed proximally, the device migrated distally of intended position.Angiography confirmed that, after the second ctag/ac was deployed distally as planned, a proximal type i endoleak was revealed.Since the patient had shaggy aorta, the physician elected to place a additional stent graft instead of ballooning, and the endoleak was resolved.The patient tolerated the procedure.(captured by (b)(4)).Immediately after tevar, it was confirmed that the patient was able to move both legs.On (b)(6) 2022, 2 days after tevar, complete paraplegia was confirmed.Further information was not available.(captured by (b)(4)).
|
|
Manufacturer Narrative
|
Device evaluated by mfr: code "other" was selected as the medical device remains implanted.Return not possible.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Search Alerts/Recalls
|
|
|